Pharmaceutical Industry Blog

Last Updated: August 26, 2026 TL;DR: Kuwait is the Gulf market where price and partner are the same decision, and both are close to irreversible. Medicines are registered by the Pharmaceutical and Herbal Medicines Registration and Control Administration of the Ministry of Health, under Ministerial Decree No. 302/1980 as updated by Ministerial Decree No. 361 of 2019, in a two-stage sequence: the Kuwaiti agent is qualified first, then the marketing authorisation holder and each

Last Updated: August 26, 2026 TL;DR: Costa Rica has two gates, and most first-time exporters only plan for the first one. The Ministerio de Salud grants the sanitary registration that makes your injectable legal to sell – filed on the Registrelo platform, valid for five years, under the Central American technical regulation RTCA 11.03.59, and requiring an apostilled certificate of pharmaceutical product or GMP certificate plus a locally domiciled legal representative. The sec

Last Updated: August 25, 2026 TL;DR: Oman is a high-maturity Gulf market with a regulator that is publishing its rulebook in the open. Medicines are handled by the Drug Safety Center of the Ministry of Health – the current body, replacing the older Directorate General naming that still circulates in secondary commentary – which registers first the company and then the product, entirely through the Ministry's e-portal, with a Technical Committee for Registration and Prices tak

Last Updated: August 25, 2026 TL;DR: Palestine is a market defined by two things a supplier has to plan around: a two-sided clearance requirement, and a public procurement channel that only a local partner can enter. Medicines are regulated by the General Directorate of Pharmacy and its Drug Registration Department within the Palestinian Ministry of Health, and the US International Trade Administration records that both Israeli and Palestinian Ministry of Health approvals and

Last Updated: August 24, 2026 TL;DR: The Central African Republic is a humanitarian-led market with almost no domestic manufacturing and a regulatory system still being rebuilt. Medicines are overseen by the Ministere de la Sante et de la Population through its pharmaceutical services directorate, which issues marketing authorisations, licenses pharmaceutical establishments and controls importation through authorised ports of entry, but publishes no fee schedule, review clock

Last Updated: August 24, 2026 TL;DR: Liberia is a small, donor-supported market with an unusually clear rulebook. The Liberia Medicines and Health Products Regulatory Authority (LMHRA), established under the LMHRA Act of 2010, requires every medicine sold in the country to be registered, accepts dossiers in WAHO Common Technical Document format, grants registrations valid for three years and commits to processing applications within three months of acknowledged receipt and pa